Method for enhancing the activity of CIK cells, CIK cells, and preparation method and application thereof
A cell activity and cell technology, applied in the field of cell engineering, can solve problems such as large side effects, increased risk of CIK cell therapy, lack of tumor antigen specificity, etc., achieving the effect of no toxic side effects, considerable effect, and enhanced killing activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] This example is used to illustrate the preparation of CIK cells of the present invention.
[0039] (1) Collect venous blood from patients with cancer (ovarian cancer, lung cancer, colon cancer, and gastric cancer) in a vacuum tube containing heparin, and use lymphocyte separation medium and density gradient centrifugation to separate mononuclear cells (PBMCs).
[0040] (2) After PBMCs were washed three times with normal saline, they were placed in CIK cell culture medium GT-T551 containing 0.6 vol% autologous serum, and the final cell concentration was adjusted to 2×10 6 Cells / ml; Cells were inoculated into 75 cm cell culture flasks coated with CD3 monoclonal antibody at a final concentration of 5 μg / ml and RetroNectin at a final concentration of 10 μg / ml. Add human protein interferon-γ and 1000U / ml human interleukin-2 to the medium at a final concentration of 1000U / ml, at 37°C, 5% CO 2 cultured in an incubator.
[0041] (3) On the fourth day, 100 ml of CIK cell cultu...
Embodiment 2
[0046] This example is used to illustrate the phenotype analysis of CIK cells of the present invention.
[0047] CIK cells treated with different doses of decitabine in Example 1 were phenotype detected by flow cytometry, and CD3 + CD56 + , CD8 + CD56 + and CD3 + CD8 + cell ratio.
[0048] like figure 1 A and figure 1 As shown in B, as the dose of decitabine increased, CD3 + CD56 + The proportion of cells increased accordingly, being 4.52%, 4.81%, 8.04% and 19.45% respectively; CD8 + CD56 + The proportion of cells also increased, respectively 3.55%, 4.08%, 6.89% and 16.4%; while CD3 + CD8 + The proportion of cells was not significantly different. In addition, the proportion of CD3 / CD56 double-positive effector cells in CIK cells in patients with various tumor types such as lung cancer, colon cancer, and gastric cancer has a certain increase (respectively as figure 1 C. figure 1 D and figure 1 E shown).
Embodiment 3
[0050] This example is used to illustrate the effect of DNA demethylation drugs on the proliferation activity of CIK cells.
[0051] CIK cells were prepared according to the method of Example 1, and different groups of CIK cells were counted by a cell counter, and the statistical results were as follows: figure 2 shown. from figure 2 It can be seen that DNA demethylation drugs can enhance the proliferation activity of CIK cells.
PUM

Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com